China's vaccine production speeds up in 2021, Sinopharm's Beijing company's production capacity can reach more than 1 billion doses
China News Service, Beijing, January 5 (Reporter Liu Yuying) The reporter learned from the Ministry of Industry and Information Technology of China on the 5th that China is speeding up the construction of new crown virus vaccine production capacity. The three companies have started the "acceleration" mode. Sinopharm Zhongsheng Beijing Company will be in 2021. The production capacity of inactivated new coronavirus vaccine can reach more than 1 billion doses.
According to reports, in order to meet the needs of new crown virus vaccination for key populations at this stage, Sinopharm Zhongsheng Beijing Company, Sinopharm Zhongsheng Wuhan Company, and Beijing Kexing Zhongwei Company have started the "acceleration" mode, and will not stop work and production during the New Year's Day holiday. , The company personnel work with high intensity and full load, racing against time and organizing production around the clock.
Zhang Jin, the production leader of the new crown virus inactivated vaccine project of Sinopharm Beijing Company, said that the capacity expansion plan will be implemented to meet production needs. The capacity of new crown virus inactivated vaccines in 2021 can reach more than 1 billion doses.
Sinopharm Zhongsheng Wuhan Co., Ltd. and Beijing Kexing Zhongwei Co., Ltd. are also making every effort to accelerate capacity expansion to ensure the demand for new coronavirus vaccination.
On December 30, 2020, the new coronavirus inactivated vaccine of Sinopharm Zhongsheng Beijing Company was approved by the State Food and Drug Administration for conditional listing.
Previously, Sinopharm Zhongsheng Wuhan Company and Beijing Kexing Zhongwei Company's new coronavirus inactivated vaccines were approved for emergency use. The vaccines of the above three companies have begun to vaccinate key populations.
At present, 18 domestic companies in China have successively started construction of new coronavirus vaccine production capacity.
The Ministry of Industry and Information Technology requires the acceleration of production capacity construction, and all companies on various technical routes require simultaneous promotion of production capacity construction. The three companies of Sinopharm Zhongsheng Beijing Company, Sinopharm Zhongsheng Wuhan Company, and Beijing Kexing Zhongwei Company have completed the 2020 production capacity construction task. With all the conditions for large-scale production, the capacity construction of other enterprises is also proceeding in an orderly manner as planned.
In order to ensure the smooth flow of the vaccine production and supply chain, the Ministry of Industry and Information Technology has conducted a comprehensive review of the new crown virus vaccine production and supply chain, instructing enterprises to conduct research and analysis on the supply risks of production materials, and at the same time promote key materials to accelerate production technology research, and organize upstream and downstream enterprises to strengthen supply and demand. Ensure the stability of the new coronavirus vaccine production and supply chain.
(Finish)